Ionis Pharmaceuticals(IONS) - 2024 Q4 - Earnings Call Presentation

YE:2024 Business Update and Financial Results February 19, 2025 Nasdaq: IONS 1 On Today's Earnings Call Beth Hougen Chief Financial Officer 2 Brett Monia, Ph.D. Chief Executive Officer Kyle Jenne Chief Global Product Strategy Officer Richard Geary, Ph.D. Chief Development Officer Eric Swayze, Ph.D. Executive Vice President, Research Forward-Looking Statements This presentation includes forward-looking statements regarding our business, financial guidance and the therapeutic and commercial potential of our c ...